https://www.selleckchem.com/pr....oducts/isa-2011b.htm
Copyright © 2020 Noura A. Abouammoh and Muteb A. Alshamrani.5-14% of patients underwent surgery for benign prostate hyperplasia harboring prostate cancer (PCa) focus. The best management of incidental prostate cancer (iPCa) has been debated. The decision "treatment or no treatment" should be determined by predictors which accurately foretell PCa progression after transurethral resection of the prostate (TURP). The purpose of this study is to review the available data that can be useful in daily clinical judgment. Transrectal ultrasoun